Get access

Transplantation tolerance and its outcome during infections and inflammation


  • Anita S. Chong,

    Corresponding author
    1. Section of Transplantation, Department of Surgery, The University of Chicago, Chicago, IL, USA
    • Correspondence to:

      Anita S. Chong

      5841 S. Maryland Ave

      Section of Transplantation, Department of Surgery

      The University of Chicago

      Chicago, IL 60637, USA

      Tel.: +1 773 702 5521

      Fax: +1 773 702 5517


    Search for more papers by this author
  • Maria-Luisa Alegre

    1. Section of Rheumatology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    Search for more papers by this author


Much progress has been made toward understanding the mechanistic basis of transplantation tolerance in experimental models, which implicates clonal deletion of alloreactive T and B cells, induction of cell-intrinsic hyporesponsiveness, and dominant regulatory cells mediating infectious tolerance and linked suppression. Despite encouraging success in the laboratory, achieving tolerance in the clinic remains challenging, although the basis for these challenges is beginning to be understood. Heterologous memory alloreactive T cells generated by infections prior to transplantation have been shown to be a critical barrier to tolerance induction. Furthermore, infections at the time of transplantation and tolerance induction provide a pro-inflammatory milieu that alters the stability and function of regulatory T cells as well as the activation requirements and differentiation of effector T cells. Thus, infections can result in enhanced alloreactivity, resistance to tolerance induction, and destabilization of the established tolerance state. We speculate that these experimental findings have relevance to the clinic, where infections have been associated with allograft rejection and may be a causal event precipitating the loss of grafts after long periods of stable operational tolerance. Understanding the mechanisms by which infections prevent and destabilize tolerance can lead to therapies that promote stable life-long tolerance in transplant recipients.